Two Olympia boys have Duchenne muscular dystrophy, but only one is eligible for a new treatment
In June, the U.S. Food and Drug Administration (FDA) approved the use of the first gene therapy for Duchenne muscular dystrophy, but only for kids ages 4 and 5.